• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Personalized cancer vaccines; Medicare drug price negotiations; cannabinoids for broken bone repair – Morning Medical Update


The top news stories in medicine today.

physician doctor hands with morning coffee: © kwanchaichaiudom - stock.adobe.com

© kwanchaichaiudom - stock.adobe.com

Cancer vaccines around the corner?

Even with all the health care developments and technology up to 2024, personalized cancer vaccines may seem like a far-off medical dream. Actually, they may be a medical reality much sooner than you think, said one expert discussing results of a new test of mRNA shots. “We are way closer than we ever thought,” with potential for review by the U.S. Food and Drug Administration as early as 2025.

Let’s make a drug price deal

Negotiating drug prices for Medicare will lead to lower prices and thus cost savings, right? Not if the U.S. Department of Health and Human Services (HHS) doesn’t have information about prices and rebates in price talks between pharmaceutical makers and other buyers. Two scholars argue HHS may not have a full picture about drug prices as it bargains with Big Pharma.

Cannabinoids vs. broken bones

A new study found cannabinoids helped reduce pain and promote bone fracture repair better than nonsteroidal anti-inflammatory drugs. Researchers say more information is needed before physicians can send patients home with cannabidiol and cannabigerol compounds, along with casts and crutches.

Related Videos
Victor J. Dzau, MD, gives expert advice
Victor J. Dzau, MD, gives expert advice
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice
Monica Verduzco-Gutierrez, MD, FAAPMR, gives expert advice